The accumulated number of registered patients divided in RA, early RA, bio-naïve patients, and patients who are no longer treated in the clinic (ended).
The distribution of diagnoses in the registry. The bar shows the ratio between women and men with current diagnosis.
Treatment of early RA patients between 1999 and 2012 (at 12 months of treatment visits).
Methotrexate Methotrexate, Salazopyrin Salazopyrin
Komb. dmard Combination of DMARDs, Komb. bio dmard Combination of DMARDs and Biological treatment
Median disease duration at first visit for all early RA patients, years 1999-2013
Changes in DAS28 for patients with early RA from baseline to 2 years follow-up, all inclusion years
Nothern Stockholm Southeast South Uppsala-Örebro West
MK1 MK3 MK6 MK12 MK24 (MK = monthly monitoring)
For more results, please visit: http://srq.nu/arsrapporter/